Abstract |
Ten cases of bacterial infections, showing no or insufficient response to antibacterial chemotherapy, were treated with a new intravenous human gamma-globulin (SM-4300). SM-4300 was administered intravenously (68-172 mg/kg/day) once a day for 1-3 days. SM-4300 was effective in 6 out of 8 pneumonia cases and also in 1 out of 2 septicemia cases. In none of the 10 cases, any side effects were observed.
|
Authors | N Suzuki, A Watanabe |
Journal | The Japanese journal of antibiotics
(Jpn J Antibiot)
Vol. 38
Issue 9
Pg. 2571-6
(Sep 1985)
ISSN: 0368-2781 [Print] Japan |
PMID | 4079022
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Immunoglobulins
- SM-4300
|
Topics |
- Adolescent
- Anti-Bacterial Agents
(administration & dosage)
- Bacteria
(immunology)
- Bacterial Infections
(therapy)
- Bronchopneumonia
(therapy)
- Child
- Child, Preschool
- Drug Evaluation
- Drug Resistance, Microbial
- Drug Therapy, Combination
- Female
- Humans
- Immunization, Passive
- Immunoglobulins
(administration & dosage)
- Infant
- Male
- Pneumonia
(therapy)
|